119 related articles for article (PubMed ID: 7841733)
1. Lung function in adolescents with alpha 1-antitrypsin deficiency.
Sveger T; Piitulainen E; Arborelius M
Acta Paediatr; 1994 Nov; 83(11):1170-3. PubMed ID: 7841733
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies.
Piitulainen E; Carlson J; Ohlsson K; Sveger T
Chest; 2005 Oct; 128(4):2076-81. PubMed ID: 16236857
[TBL] [Abstract][Full Text] [Related]
3. The liver in adolescents with alpha 1-antitrypsin deficiency.
Sveger T; Eriksson S
Hepatology; 1995 Aug; 22(2):514-7. PubMed ID: 7635419
[TBL] [Abstract][Full Text] [Related]
4. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
5. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
6. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
7. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
[TBL] [Abstract][Full Text] [Related]
8. Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.
Sveger T; Thelin T
Acta Paediatr Scand; 1981 Mar; 70(2):171-7. PubMed ID: 6972148
[TBL] [Abstract][Full Text] [Related]
9. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
[TBL] [Abstract][Full Text] [Related]
10. Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency.
Piitulainen E; Sveger T
Acta Paediatr; 1998 Nov; 87(11):1120-4. PubMed ID: 9846912
[TBL] [Abstract][Full Text] [Related]
11. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
Piitulainen E; Sveger T
Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
[TBL] [Abstract][Full Text] [Related]
12. The natural history of liver disease in alpha 1-antitrypsin deficient children.
Sveger T
Acta Paediatr Scand; 1988 Nov; 77(6):847-51. PubMed ID: 2905108
[TBL] [Abstract][Full Text] [Related]
13. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
Piitulainen E; Tanash HA
COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
[TBL] [Abstract][Full Text] [Related]
15. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
[TBL] [Abstract][Full Text] [Related]
16. European screening for alpha
Greulich T; Averyanov A; Borsa L; Rozborilová E; Vaicius D; Major T; Chopyak V; Tudorache V; Konstantinova T; Camprubí S
Clin Respir J; 2017 Jan; 11(1):90-97. PubMed ID: 25919395
[TBL] [Abstract][Full Text] [Related]
17. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?
Seersholm N; Kok-Jensen A
Respir Med; 1998 Feb; 92(2):241-5. PubMed ID: 9616519
[TBL] [Abstract][Full Text] [Related]
18. Plasma protease inhibitors in alpha 1-antitrypsin-deficient children.
Sveger T
Pediatr Res; 1985 Aug; 19(8):834-5. PubMed ID: 3875830
[TBL] [Abstract][Full Text] [Related]
19. A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency.
Kramps JA; Bakker W; Dijkman JH
Am Rev Respir Dis; 1980 Feb; 121(2):253-61. PubMed ID: 6965829
[TBL] [Abstract][Full Text] [Related]
20. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
